lobbying_activities: 2103310

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2103310	3bd7e7ac-d45f-4c97-962b-b74b827d5ea2	Q1	INDEPENDENT PHARMACY COOPERATIVE	313098	INDEPENDENT PHARMACY COOPERATIVE	2018	first_quarter	PHA	Medicare CONTRACT YEAR 2019 POLICY AND TECHNICAL CHANGES comments. Support drug price concessions at the point of sale and limiting excessive pharmacy credentialing requirements. Oppose proposed changes to LIS dual-eligible Special Enrollment Period (SEP). Support S. 109/H.R. 592, the Pharmacy and Medically Underserved Areas Enhancement Act Support S.413/H.R. 1038, the "Improving Transparency and Accuracy in Medicare Part D Drug Spending Act. Ensure patient choice in Comprehensive Addiction and Recovery Act of 2016 lock-in provision. Support S. 413 / H.R. 1038 the "Improving Transparency and Accuracy in Medicare Part D Drug Spending Act"	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE		30000	0	0	2018-04-10T13:38:22.923000-04:00